Prevention and management of adverse events related to regorafenib View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-03

AUTHORS

Mieke De Wit, Christine B. Boers-Doets, Alessandra Saettini, Kristina Vermeersch, Carmen Roncero de Juan, Jan Ouwerkerk, See-See Raynard, Ashley Bazin, Chiara Cremolini

ABSTRACT

Regorafenib is an oral multikinase inhibitor that has shown antitumor activity in a range of solid tumors. Based on data from phase III clinical trials, regorafenib is indicated for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not considered candidates for, other available therapies, and in patients with advanced gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other appropriate treatments. A panel of oncology nurses, research coordinators, and other medical oncology experts, experienced in the care of patients treated with regorafenib, met to discuss the best practice for the management of regorafenib-associated adverse events (AEs). The panel agreed that, in clinical trials and daily practice with regorafenib, AEs are common but mostly manageable. The most common and/or important AEs associated with regorafenib were considered to be hand-foot skin reaction, rash or desquamation, stomatitis, diarrhea, hypertension, liver abnormalities, and fatigue. This manuscript describes the experience and recommendations of the panel for managing these AEs in everyday clinical practice. Appropriate education, monitoring, and management are considered essential for reducing the incidence, duration, and severity of regorafenib-associated AEs. More... »

PAGES

837-846

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00520-013-2085-z

DOI

http://dx.doi.org/10.1007/s00520-013-2085-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1004735391

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24337717


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exanthema", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fatigue", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Foot", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Stromal Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Universitaire Ziekenhuizen Leuven", 
          "id": "https://www.grid.ac/institutes/grid.410569.f", 
          "name": [
            "Digestive Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Wit", 
        "givenName": "Mieke", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boers-Doets", 
        "givenName": "Christine B.", 
        "id": "sg:person.0744115135.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744115135.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Medical Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saettini", 
        "givenName": "Alessandra", 
        "id": "sg:person.0701761306.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701761306.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universitaire Ziekenhuizen Leuven", 
          "id": "https://www.grid.ac/institutes/grid.410569.f", 
          "name": [
            "Digestive Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vermeersch", 
        "givenName": "Kristina", 
        "id": "sg:person.0732035745.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732035745.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario La Paz", 
          "id": "https://www.grid.ac/institutes/grid.81821.32", 
          "name": [
            "Oncology Department, Clinical Trials, Hospital La Paz, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Juan", 
        "givenName": "Carmen Roncero", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ouwerkerk", 
        "givenName": "Jan", 
        "id": "sg:person.01126456735.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126456735.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alberta", 
          "id": "https://www.grid.ac/institutes/grid.17089.37", 
          "name": [
            "Cross Cancer Institute, Edmonton, AB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raynard", 
        "givenName": "See-See", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tallaght Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413305.0", 
          "name": [
            "Oncology Clinical Trials, Tallaght Hospital, Tallaght, Dublin, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bazin", 
        "givenName": "Ashley", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Medical Oncology Unit 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cremolini", 
        "givenName": "Chiara", 
        "id": "sg:person.01257327771.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257327771.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.12-s1-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003989132"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrcardio.2010.121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011332716", 
          "https://doi.org/10.1038/nrcardio.2010.121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrcardio.2010.121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011332716", 
          "https://doi.org/10.1038/nrcardio.2010.121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1368-8375(98)00068-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012897411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.25864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013704343"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-1900", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018407352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61857-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019579715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61900-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020430219"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ncc.0b013e3182791097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024858434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ncc.0b013e3182791097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024858434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ncc.0b013e3182791097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024858434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehs181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025101754"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0019-5154.74562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025637787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00365529709011203", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035451091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2012.05.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035790264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1548-5315(11)70385-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054717852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.26.15_suppl.20713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079371771"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.31.4_suppl.467", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083953316"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-03", 
    "datePublishedReg": "2014-03-01", 
    "description": "Regorafenib is an oral multikinase inhibitor that has shown antitumor activity in a range of solid tumors. Based on data from phase III clinical trials, regorafenib is indicated for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not considered candidates for, other available therapies, and in patients with advanced gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other appropriate treatments. A panel of oncology nurses, research coordinators, and other medical oncology experts, experienced in the care of patients treated with regorafenib, met to discuss the best practice for the management of regorafenib-associated adverse events (AEs). The panel agreed that, in clinical trials and daily practice with regorafenib, AEs are common but mostly manageable. The most common and/or important AEs associated with regorafenib were considered to be hand-foot skin reaction, rash or desquamation, stomatitis, diarrhea, hypertension, liver abnormalities, and fatigue. This manuscript describes the experience and recommendations of the panel for managing these AEs in everyday clinical practice. Appropriate education, monitoring, and management are considered essential for reducing the incidence, duration, and severity of regorafenib-associated AEs. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00520-013-2085-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1103473", 
        "issn": [
          "0941-4355", 
          "1433-7339"
        ], 
        "name": "Supportive Care in Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Prevention and management of adverse events related to regorafenib", 
    "pagination": "837-846", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "169056f1bdf0874d0546f83d5b45b0a891e8799ecac351b09a8ea05ed3402285"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24337717"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9302957"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00520-013-2085-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1004735391"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00520-013-2085-z", 
      "https://app.dimensions.ai/details/publication/pub.1004735391"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88257_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00520-013-2085-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-013-2085-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-013-2085-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-013-2085-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-013-2085-z'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      56 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00520-013-2085-z schema:about N06b1e886165e463c83eb860fefe32801
2 N193761847b57464480a8a18c632766e9
3 N1e1b01f99d8342258482ffc37fbd6b22
4 N26e0ca94a0d145ffad35da5547c778ed
5 N2cad3e5104004f2293289261c18c0777
6 N535c26c63bfd406882dad42cf3c98e8a
7 N8d53281fd13f49aaa3e8f80f72af7f9d
8 N94435afa8b0e45b28a42dd3912a9428c
9 Na03f24462a7f434abfdbfa0fc92b84e7
10 Nc05d0eaa5e6347f7bacc617753b2fac0
11 Ncbdd9d1fa42d402a9710b58cca5c5f61
12 Ne5ed68358e4c404d9676b85c8c75e3a1
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N70c03ee6ad8e40a983041210156355f2
16 schema:citation sg:pub.10.1038/nrcardio.2010.121
17 https://doi.org/10.1002/ijc.25864
18 https://doi.org/10.1016/j.jpainsymman.2012.05.006
19 https://doi.org/10.1016/s0140-6736(12)61857-1
20 https://doi.org/10.1016/s0140-6736(12)61900-x
21 https://doi.org/10.1016/s1368-8375(98)00068-2
22 https://doi.org/10.1016/s1548-5315(11)70385-0
23 https://doi.org/10.1093/eurheartj/ehs181
24 https://doi.org/10.1097/ncc.0b013e3182791097
25 https://doi.org/10.1158/1078-0432.ccr-11-1900
26 https://doi.org/10.1200/jco.2008.26.15_suppl.20713
27 https://doi.org/10.1200/jco.2013.31.4_suppl.467
28 https://doi.org/10.1634/theoncologist.12-s1-4
29 https://doi.org/10.3109/00365529709011203
30 https://doi.org/10.4103/0019-5154.74562
31 schema:datePublished 2014-03
32 schema:datePublishedReg 2014-03-01
33 schema:description Regorafenib is an oral multikinase inhibitor that has shown antitumor activity in a range of solid tumors. Based on data from phase III clinical trials, regorafenib is indicated for the treatment of adult patients with metastatic colorectal cancer who have previously been treated with, or are not considered candidates for, other available therapies, and in patients with advanced gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other appropriate treatments. A panel of oncology nurses, research coordinators, and other medical oncology experts, experienced in the care of patients treated with regorafenib, met to discuss the best practice for the management of regorafenib-associated adverse events (AEs). The panel agreed that, in clinical trials and daily practice with regorafenib, AEs are common but mostly manageable. The most common and/or important AEs associated with regorafenib were considered to be hand-foot skin reaction, rash or desquamation, stomatitis, diarrhea, hypertension, liver abnormalities, and fatigue. This manuscript describes the experience and recommendations of the panel for managing these AEs in everyday clinical practice. Appropriate education, monitoring, and management are considered essential for reducing the incidence, duration, and severity of regorafenib-associated AEs.
34 schema:genre research_article
35 schema:inLanguage en
36 schema:isAccessibleForFree true
37 schema:isPartOf N1f4850b5f78e4c5b8d885c6c715db18a
38 N2dc1bae5395345b78c0ef959657f7308
39 sg:journal.1103473
40 schema:name Prevention and management of adverse events related to regorafenib
41 schema:pagination 837-846
42 schema:productId N0cf7e1d6260247ca8fe68e3c8bf37747
43 N10963bd5aecc4aa5bc1e632132950acc
44 N6a2b361847674e6393143a636dec900f
45 N9c7e2c9c11d94b9ba98188273c7ead05
46 Necb7ef598ceb4566ab999587e20ae5d1
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004735391
48 https://doi.org/10.1007/s00520-013-2085-z
49 schema:sdDatePublished 2019-04-11T13:12
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher Nac5ce5e59022471eb19ed7a386fc2350
52 schema:url http://link.springer.com/10.1007%2Fs00520-013-2085-z
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N02bf1aceb85a4a6aa8b176b9072a255c rdf:first sg:person.0744115135.58
57 rdf:rest N3340686c9c344435906fd9095b988625
58 N06b1e886165e463c83eb860fefe32801 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Hypertension
60 rdf:type schema:DefinedTerm
61 N0815b2bc1c3f46a49cd154ddae7bf7aa rdf:first Nbaaf671ccc3c462698dcce1e35f2806b
62 rdf:rest Na63fad30a795406c9c9bd83c15754896
63 N0cf7e1d6260247ca8fe68e3c8bf37747 schema:name pubmed_id
64 schema:value 24337717
65 rdf:type schema:PropertyValue
66 N10963bd5aecc4aa5bc1e632132950acc schema:name nlm_unique_id
67 schema:value 9302957
68 rdf:type schema:PropertyValue
69 N14c17c9b3fe94a38b84eb4030a93199a rdf:first sg:person.01126456735.44
70 rdf:rest N0815b2bc1c3f46a49cd154ddae7bf7aa
71 N193761847b57464480a8a18c632766e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Foot
73 rdf:type schema:DefinedTerm
74 N1e1b01f99d8342258482ffc37fbd6b22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Phenylurea Compounds
76 rdf:type schema:DefinedTerm
77 N1f4850b5f78e4c5b8d885c6c715db18a schema:issueNumber 3
78 rdf:type schema:PublicationIssue
79 N26e0ca94a0d145ffad35da5547c778ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Antineoplastic Agents
81 rdf:type schema:DefinedTerm
82 N2cad3e5104004f2293289261c18c0777 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Adult
84 rdf:type schema:DefinedTerm
85 N2dc1bae5395345b78c0ef959657f7308 schema:volumeNumber 22
86 rdf:type schema:PublicationVolume
87 N327a330d19df43b89369231f3dc1cb5c schema:affiliation https://www.grid.ac/institutes/grid.410569.f
88 schema:familyName De Wit
89 schema:givenName Mieke
90 rdf:type schema:Person
91 N332305a1e3e9437aab657446a17d1831 rdf:first sg:person.01257327771.59
92 rdf:rest rdf:nil
93 N3340686c9c344435906fd9095b988625 rdf:first sg:person.0701761306.14
94 rdf:rest Nd9981d9bd15c471aa0d6deef60d1427d
95 N535c26c63bfd406882dad42cf3c98e8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Gastrointestinal Stromal Tumors
97 rdf:type schema:DefinedTerm
98 N5d72af2fda624a439aa945bb3a225600 schema:affiliation https://www.grid.ac/institutes/grid.81821.32
99 schema:familyName de Juan
100 schema:givenName Carmen Roncero
101 rdf:type schema:Person
102 N6a2b361847674e6393143a636dec900f schema:name readcube_id
103 schema:value 169056f1bdf0874d0546f83d5b45b0a891e8799ecac351b09a8ea05ed3402285
104 rdf:type schema:PropertyValue
105 N70c03ee6ad8e40a983041210156355f2 rdf:first N327a330d19df43b89369231f3dc1cb5c
106 rdf:rest N02bf1aceb85a4a6aa8b176b9072a255c
107 N8d53281fd13f49aaa3e8f80f72af7f9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Exanthema
109 rdf:type schema:DefinedTerm
110 N94435afa8b0e45b28a42dd3912a9428c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Hand
112 rdf:type schema:DefinedTerm
113 N9c7e2c9c11d94b9ba98188273c7ead05 schema:name dimensions_id
114 schema:value pub.1004735391
115 rdf:type schema:PropertyValue
116 Na03f24462a7f434abfdbfa0fc92b84e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 Na63fad30a795406c9c9bd83c15754896 rdf:first Nb21da2d741d949cbb14828d4fc19d8b2
120 rdf:rest N332305a1e3e9437aab657446a17d1831
121 Nac5ce5e59022471eb19ed7a386fc2350 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 Nb21da2d741d949cbb14828d4fc19d8b2 schema:affiliation https://www.grid.ac/institutes/grid.413305.0
124 schema:familyName Bazin
125 schema:givenName Ashley
126 rdf:type schema:Person
127 Nbaaf671ccc3c462698dcce1e35f2806b schema:affiliation https://www.grid.ac/institutes/grid.17089.37
128 schema:familyName Raynard
129 schema:givenName See-See
130 rdf:type schema:Person
131 Nc05d0eaa5e6347f7bacc617753b2fac0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Colorectal Neoplasms
133 rdf:type schema:DefinedTerm
134 Ncbdd9d1fa42d402a9710b58cca5c5f61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Fatigue
136 rdf:type schema:DefinedTerm
137 Nd9981d9bd15c471aa0d6deef60d1427d rdf:first sg:person.0732035745.56
138 rdf:rest Nea6ae9d8f5eb4078b7320ca618bbf9bd
139 Ne5ed68358e4c404d9676b85c8c75e3a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Pyridines
141 rdf:type schema:DefinedTerm
142 Nea6ae9d8f5eb4078b7320ca618bbf9bd rdf:first N5d72af2fda624a439aa945bb3a225600
143 rdf:rest N14c17c9b3fe94a38b84eb4030a93199a
144 Necb7ef598ceb4566ab999587e20ae5d1 schema:name doi
145 schema:value 10.1007/s00520-013-2085-z
146 rdf:type schema:PropertyValue
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
151 schema:name Oncology and Carcinogenesis
152 rdf:type schema:DefinedTerm
153 sg:journal.1103473 schema:issn 0941-4355
154 1433-7339
155 schema:name Supportive Care in Cancer
156 rdf:type schema:Periodical
157 sg:person.01126456735.44 schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
158 schema:familyName Ouwerkerk
159 schema:givenName Jan
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126456735.44
161 rdf:type schema:Person
162 sg:person.01257327771.59 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
163 schema:familyName Cremolini
164 schema:givenName Chiara
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257327771.59
166 rdf:type schema:Person
167 sg:person.0701761306.14 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
168 schema:familyName Saettini
169 schema:givenName Alessandra
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701761306.14
171 rdf:type schema:Person
172 sg:person.0732035745.56 schema:affiliation https://www.grid.ac/institutes/grid.410569.f
173 schema:familyName Vermeersch
174 schema:givenName Kristina
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0732035745.56
176 rdf:type schema:Person
177 sg:person.0744115135.58 schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
178 schema:familyName Boers-Doets
179 schema:givenName Christine B.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744115135.58
181 rdf:type schema:Person
182 sg:pub.10.1038/nrcardio.2010.121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011332716
183 https://doi.org/10.1038/nrcardio.2010.121
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1002/ijc.25864 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013704343
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.jpainsymman.2012.05.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035790264
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s0140-6736(12)61857-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019579715
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s0140-6736(12)61900-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020430219
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s1368-8375(98)00068-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012897411
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s1548-5315(11)70385-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054717852
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1093/eurheartj/ehs181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025101754
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1097/ncc.0b013e3182791097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024858434
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1158/1078-0432.ccr-11-1900 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018407352
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1200/jco.2008.26.15_suppl.20713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079371771
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1200/jco.2013.31.4_suppl.467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083953316
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1634/theoncologist.12-s1-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003989132
208 rdf:type schema:CreativeWork
209 https://doi.org/10.3109/00365529709011203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035451091
210 rdf:type schema:CreativeWork
211 https://doi.org/10.4103/0019-5154.74562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025637787
212 rdf:type schema:CreativeWork
213 https://www.grid.ac/institutes/grid.10419.3d schema:alternateName Leiden University Medical Center
214 schema:name Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.144189.1 schema:alternateName Azienda Ospedaliera Universitaria Pisana
217 schema:name Medical Oncology Unit 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
218 Medical Oncology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
219 rdf:type schema:Organization
220 https://www.grid.ac/institutes/grid.17089.37 schema:alternateName University of Alberta
221 schema:name Cross Cancer Institute, Edmonton, AB, Canada
222 rdf:type schema:Organization
223 https://www.grid.ac/institutes/grid.410569.f schema:alternateName Universitaire Ziekenhuizen Leuven
224 schema:name Digestive Oncology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.413305.0 schema:alternateName Tallaght Hospital
227 schema:name Oncology Clinical Trials, Tallaght Hospital, Tallaght, Dublin, Ireland
228 rdf:type schema:Organization
229 https://www.grid.ac/institutes/grid.81821.32 schema:alternateName Hospital Universitario La Paz
230 schema:name Oncology Department, Clinical Trials, Hospital La Paz, Madrid, Spain
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...